Not available outside of the UK & Ireland.
Application
SB-269970 hydrochloride has been used to study the effect of different endotype combination on the activity of the 5-hydroxytryptamine receptor of tall fescue alkaloids. It has also been used to inhibit dopamine receptor signaling, in order to study its role in early hemocyte activation.
SB-269970 was used to study the role of 5-HT7 receptors in serotonin-induced hypothermia in rodents.6
Biochem/physiol Actions
Selective 5-HT7 serotonin receptor antagonist.
SB-269970 is an anti-psychotic agent that shows high affinity for 5-HT7 receptors. It may be effective in treating cognitive disabilities and schizophrenia-like deficits.4 SB-269970 desensitizes and decreases the excitatory effects of 5-HT7 receptors in rat hippocampus.5
Legal Information
Sold with the permission of GlaxoSmithKline Pharmaceuticals
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: